Use of Avastin (bevacizumab) in age related macular degeneration
Updated Statement from The Royal College of Ophthalmologists In 2011 a working group of The Royal College of Ophthalmologists released a statement regarding the use of Avastin (bevacizumab) in medical ophthalmology. It found that Avastin and Lucentis (ranibizumab) were equally effective in the treatment of neovascular age-related macular degeneration (AMD) and that there was no
Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy – (Eye 28, 1494 (December 2014))
Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy Eye 28, 1494 (December 2014). doi:10.1038/eye.2014.220 Authors: C Yu, J K Ho & Y J Liao
Choroidal thickness in regressed retinopathy of prematurity – (Eye 28, 1461 (December 2014))
Choroidal thickness in regressed retinopathy of prematurity Eye 28, 1461 (December 2014). doi:10.1038/eye.2014.207 Authors: M F Anderson, B Ramasamy, D T Lythgoe & D Clark
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome – (Eye 28, 1469 (December 2014))
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome Eye 28, 1469 (December 2014). doi:10.1038/eye.2014.222 Authors: M Ho, E C F Lo, A L Young & D T L Liu
Evaluation of choroidal thickness using spectral-domain optical coherence tomography in migraine patients during acute migraine attacks: a comparative study – (Eye 28, 1477 (December 2014))
Evaluation of choroidal thickness using spectral-domain optical coherence tomography in migraine patients during acute migraine attacks: a comparative study Eye 28, 1477 (December 2014). doi:10.1038/eye.2014.218 Authors: A Karalezli, C Simsek, G Celik & F C Eroglu